Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 74005501000001116 | Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 74005601000001117 | Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 2 (CD) | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has VMP | Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has specific active ingredient | Bupivacaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has specific active ingredient | Fentanyl citrate | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has dispensed dose form | Conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Fentanyl | true | Inferred relationship | Existential restriction modifier | ||
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Has basis of strength substance | Fentanyl | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml infusion bottles (Special Order) 1 bottle | Is a | True | Bupivacaine 156.25mg/250ml (0.0625%) / Fentanyl 500micrograms/250ml solution for infusion bottles 1 bottle | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR